Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Clinical Therapeutics|January 30, 2010
Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertensionJuan G Puig, Heribert Schunkert, Addison A Taylor, et al.Journal of Clinical Pharmacology|February 13, 2010
Influence of body weight and gender on the pharmacokinetics, pharmacodynamics, and antihypertensive efficacy of aliskirenVenkateswar Jarugula, Ching-Ming Yeh, Dan Howard, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|October 6, 2007
Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapyWaymon Drummond, Mark A Munger, Mohammed Rafique Essop, et al.Therapeutic Advances in Endocrinology and Metabolism|November 14, 2012
Antihypertensive treatment in patients with class 3 obesityJens Jordan, Sam W Boye, Stephanie Le Breton, et al.Cardiovascular Therapeutics|April 22, 2010
Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trialKarl Andersen, Myron H Weinberger, Brent Egan, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|October 30, 2008
Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertensionRainer Dietz, Ralf Dechend, Chuek-Man Yu, et al.Journal of Hypertension|February 28, 2008
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trialKarl Andersen, Myron H Weinberger, Brent Egan, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 21, 2009
Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertensionKarl Andersen, Myron H Weinberger, Christian M Constance, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|October 30, 2010
Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertensionWilliam B White, Robert Bresalier, Allen P Kaplan, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|July 19, 2011
Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12,942 patientsWilliam B White, Robert Bresalier, Allen P Kaplan, et al.Pageof 3